215 related articles for article (PubMed ID: 21503587)
1. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
[TBL] [Abstract][Full Text] [Related]
2. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
[TBL] [Abstract][Full Text] [Related]
3. Physical exercise and a leucine-rich diet modulate the muscle protein metabolism in Walker tumor-bearing rats.
Salomão EM; Toneto AT; Silva GO; Gomes-Marcondes MC
Nutr Cancer; 2010; 62(8):1095-104. PubMed ID: 21058197
[TBL] [Abstract][Full Text] [Related]
4. Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
Carbó N; Costelli P; Busquets S; López-Soriano J; López-Soriano FJ; Baccino FM; Argilés JM
Int J Mol Med; 2004 Oct; 14(4):719-23. PubMed ID: 15375607
[TBL] [Abstract][Full Text] [Related]
5. Protein metabolism in cachectic tumor-bearing rats: effect of tumor excision.
Le Bricon T; Cynober L; Baracos VE
J Surg Res; 1996 Jan; 60(1):207-15. PubMed ID: 8592416
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting.
Svaninger G; Drott C; Lundholm K
J Natl Cancer Inst; 1987 May; 78(5):943-50. PubMed ID: 3553691
[TBL] [Abstract][Full Text] [Related]
8. Leptin and leucine synergistically regulate protein metabolism in C2C12 myotubes and mouse skeletal muscles.
Mao X; Zeng X; Huang Z; Wang J; Qiao S
Br J Nutr; 2013 Jul; 110(2):256-64. PubMed ID: 23211060
[TBL] [Abstract][Full Text] [Related]
9. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
Tessitore L; Costelli P; Bonetti G; Baccino FM
Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
[TBL] [Abstract][Full Text] [Related]
10. Protein synthesis measured in vivo in muscle and liver of cachectic tumor-bearing mice.
Emery PW; Lovell L; Rennie MJ
Cancer Res; 1984 Jul; 44(7):2779-84. PubMed ID: 6722806
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of leucine supplementation on body composition.
Balage M; Dardevet D
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):265-70. PubMed ID: 20110810
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
13. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis S; Asensi M; Taillandier D; Aurousseau E; Larbaud D; Obled A; Béchet D; Ferrara M; Estrela JM; Attaix D
Cancer Res; 1994 Nov; 54(21):5568-73. PubMed ID: 7923198
[TBL] [Abstract][Full Text] [Related]
14. Effects of increased beta 2-agonist dose in tumor-bearing animals.
Stallion A; Foley-Nelson T; Chance WT; Fischer JE
Nutr Cancer; 1993; 20(3):251-60. PubMed ID: 7906412
[TBL] [Abstract][Full Text] [Related]
15. Lack of evidence for elevated breakdown rate of skeletal muscles in weight-losing, tumor-bearing mice.
Svaninger G; Bennegard K; Ekman L; Ternell M; Lundholm K
J Natl Cancer Inst; 1983 Aug; 71(2):341-6. PubMed ID: 6576191
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
[TBL] [Abstract][Full Text] [Related]
18. Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.
Bhogal AS; Lorite ML; Tisdale MJ
Anticancer Res; 2006; 26(6B):4149-54. PubMed ID: 17201126
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
Assi M; Derbré F; Lefeuvre-Orfila L; Rébillard A
Free Radic Biol Med; 2016 Feb; 91():204-14. PubMed ID: 26708754
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
